1-deoxynojirimycin has been researched along with Autoimmune Diabetes in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (58.33) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adelman, MH; Monte, SV; Paladino, JA; Schentag, JJ | 1 |
| Hamaguchi, T; Katsuno, T; Konishi, K; Kusunoki, Y; Miuchi, M; Miyagawa, J; Murai, K; Nagai, E; Namba, M; Ochi, F; Tokuda, M | 1 |
| Tattersall, R | 1 |
| Alexopoulos, E; Dimitriadis, G; Ganotakis, M; Hatziagellaki, E; Komesidou, V; Kordonouri, O; Raptis, S | 1 |
| Berzin, M; Diamond, TH; Griffiths, RF; Kalk, WJ; Osler, CE; Smit, AM; Wing, J | 1 |
| Gray, RS; Hillman, RJ; Scott, M | 1 |
| Dimitriadis, G; Hatziagelaki, E; Hillebrand, I; Ladas, S; Linos, A; Raptis, S | 1 |
| Cañizo, JF; Hillebrand, I; Navascués, I; Sabán, J; Serrano-Rios, M | 1 |
| Gerich, JE; Kennedy, FP | 2 |
| Dimitriadis, G; Halvatsiotis, P; Hatziagelaki, E; Hillebrand, I; Ladas, S; Mitrakou, A; Raptis, A; Raptis, S | 1 |
| Bachmann, W; Hillebrand, I; Lotz, N; Rinninger, F | 1 |
1 review(s) available for 1-deoxynojirimycin and Autoimmune Diabetes
| Article | Year |
|---|---|
Alpha-glucosidase inhibition as an adjunct to the treatment of type 1 diabetes.
Topics: 1-Deoxynojirimycin; Acarbose; Blood Glucose; Diabetes Mellitus, Type 1; Eating; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemia; Imino Pyranoses; Trisaccharides | 1993 |
8 trial(s) available for 1-deoxynojirimycin and Autoimmune Diabetes
| Article | Year |
|---|---|
Effects of miglitol in combination with intensive insulin therapy on blood glucose control with special reference to incretin responses in type 1 diabetes mellitus.
Topics: 1-Deoxynojirimycin; Adult; Aged; Deoxyglucose; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Enzyme Inhibitors; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Incretins; Insulin; Male; Middle Aged; Serum Albumin; Weight Loss; Young Adult | 2011 |
The acute effects of glucosidase inhibition on post-meal glucose increments in insulin-dependent diabetics.
Topics: 1-Deoxynojirimycin; Adult; Blood Glucose; Diabetes Mellitus, Type 1; Double-Blind Method; Female; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Imino Pyranoses; Insulin; Male; Middle Aged; Randomized Controlled Trials as Topic; Time Factors | 1990 |
Effect of alpha-glucosidase inhibition on glucose profiles in insulin dependent diabetes.
Topics: 1-Deoxynojirimycin; Adult; Blood Glucose; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 1; Glucosamine; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Imino Pyranoses; Insulin; Middle Aged; Triglycerides | 1989 |
Effects of prolonged administration of two new alpha-glucosidase inhibitors on blood glucose control, insulin requirements and breath hydrogen excretion in patients with insulin-dependent diabetes mellitus.
Topics: 1-Deoxynojirimycin; Adult; Anti-Bacterial Agents; Blood Glucose; Breath Tests; Diabetes Mellitus, Type 1; Drug Administration Schedule; Glucosamine; Humans; Hydrogen; Imino Pyranoses; Insulin; Male | 1988 |
Effect of two new alpha-glucosidase inhibitors in insulin-dependent diabetic patients.
Topics: 1-Deoxynojirimycin; Adult; Diabetes Mellitus, Type 1; Diet; Double-Blind Method; Female; Glucosamine; Glucosidases; Humans; Hyperglycemia; Hypoglycemia; Imino Pyranoses; Insulin; Male; Random Allocation | 1988 |
A new alpha-glucosidase inhibitor (Bay-m-1099) reduces insulin requirements with meals in insulin-dependent diabetes mellitus.
Topics: 1-Deoxynojirimycin; Anti-Bacterial Agents; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Dietary Carbohydrates; Eating; Female; Glucosamine; Humans; Imino Pyranoses; Insulin; Male; Random Allocation | 1987 |
Effects of two new alpha-glucosidase inhibitors on glycemic control in patients with insulin-dependent diabetes mellitus.
Topics: 1-Deoxynojirimycin; Adult; Blood Glucose; Breath Tests; Clinical Trials as Topic; Deuterium; Diabetes Mellitus, Type 1; Double-Blind Method; Glucosamine; Humans; Imino Pyranoses; Insulin; Insulin Infusion Systems; Male; Random Allocation | 1986 |
[Miglitol in the treatment of the insulin-dependent diabetic patient. Improved metabolic control and excellent tolerance].
Topics: 1-Deoxynojirimycin; Adult; Blood Glucose; Diabetes Mellitus, Type 1; Glucosamine; Glycated Hemoglobin; Humans; Imino Pyranoses | 1987 |
3 other study(ies) available for 1-deoxynojirimycin and Autoimmune Diabetes
| Article | Year |
|---|---|
Glucose supply and insulin demand dynamics of antidiabetic agents.
Topics: 1-Deoxynojirimycin; Acarbose; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dietary Carbohydrates; Energy Intake; Follow-Up Studies; Gluconeogenesis; Glucose; Glycated Hemoglobin; Heart Diseases; Homeostasis; Humans; Hypoglycemic Agents; Insulin; Intestinal Absorption; Liver; Metformin; Myocardial Infarction; Thiazolidinediones | 2010 |
Effects of alpha-glucosidase inhibition on meal glucose tolerance and timing of insulin administration in patients with type I diabetes mellitus.
Topics: 1-Deoxynojirimycin; Adult; Blood Glucose; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Eating; Energy Intake; Glucosamine; Glucose Clamp Technique; Glycoside Hydrolase Inhibitors; Humans; Imino Pyranoses; Insulin; Male | 1991 |
Alpha-glucosidase inhibition and timing of preprandial insulin in patients with insulin-dependent diabetes mellitus (IDDM).
Topics: 1-Deoxynojirimycin; Blood Glucose; Diabetes Mellitus, Type 1; Drug Administration Schedule; Eating; Female; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Imino Pyranoses; Insulin; Kinetics; Male | 1988 |